LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | PLX-4720 | 0.04 | uM | LJP5 | 1 | K06 | 72 | hr | 1389 | 6143 | 5772 | 1.0642 | 1.0615 |
MCF7 | Tozasertib | 0.04 | uM | LJP5 | 1 | B18 | 72 | hr | 1389 | 1596 | 5772 | 0.2765 | 0.0699 |
MCF7 | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 1389 | 1524 | 6038 | 0.2524 | 0.0447 |
MCF7 | GW843682X | 0.04 | uM | LJP6 | 1 | B18 | 72 | hr | 1389 | 4095 | 5147 | 0.7956 | 0.7721 |
MCF7 | GW843682X | 0.04 | uM | LJP6 | 2 | B18 | 72 | hr | 1389 | 5070 | 5447 | 0.9306 | 0.9284 |
MCF7 | AZD7762 | 0.04 | uM | LJP6 | 2 | L06 | 72 | hr | 1389 | 2012 | 5447 | 0.3693 | 0.2067 |
MCF7 | GW843682X | 0.04 | uM | LJP6 | 3 | B18 | 72 | hr | 1389 | 4520 | 5740 | 0.7874 | 0.7796 |
MCF7 | Sigma A6730 | 0.04 | uM | LJP5 | 1 | B24 | 72 | hr | 1389 | 4210 | 5772 | 0.7293 | 0.7153 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 3 | J06 | 72 | hr | 1389 | 6077 | 6038 | 1.0064 | 1.0060 |
MCF7 | NVP-TAE684 | 0.04 | uM | LJP6 | 1 | K18 | 72 | hr | 1389 | 3856 | 5147 | 0.7492 | 0.7166 |
MCF7 | Torin1 | 0.04 | uM | LJP6 | 1 | O18 | 72 | hr | 1389 | 1824 | 5147 | 0.3544 | 0.1551 |
MCF7 | Sorafenib | 0.04 | uM | LJP6 | 3 | B12 | 72 | hr | 1389 | 5350 | 5740 | 0.9320 | 0.9323 |
MCF7 | AZD7762 | 0.04 | uM | LJP6 | 3 | L06 | 72 | hr | 1389 | 1929 | 5740 | 0.3360 | 0.1740 |
MCF7 | Imatinib | 0.04 | uM | LJP6 | 1 | N18 | 72 | hr | 1389 | 5897 | 5147 | 1.1457 | 1.1493 |
MCF7 | Imatinib | 0.04 | uM | LJP6 | 2 | N18 | 72 | hr | 1389 | 6052 | 5447 | 1.1109 | 1.1096 |
MCF7 | Imatinib | 0.04 | uM | LJP6 | 3 | N18 | 72 | hr | 1389 | 6001 | 5740 | 1.0454 | 1.0438 |
MCF7 | Sorafenib | 0.04 | uM | LJP6 | 1 | B12 | 72 | hr | 1389 | 4484 | 5147 | 0.8712 | 0.8592 |
MCF7 | Lapatinib | 0.04 | uM | LJP6 | 3 | M24 | 72 | hr | 1389 | 4650 | 5740 | 0.8100 | 0.8044 |
MCF7 | Lapatinib | 0.04 | uM | LJP6 | 2 | M24 | 72 | hr | 1389 | 5016 | 5447 | 0.9207 | 0.9179 |
MCF7 | WZ-4-145 | 0.04 | uM | LJP6 | 3 | J24 | 72 | hr | 1389 | 4359 | 5740 | 0.7593 | 0.7483 |
MCF7 | Sorafenib | 0.04 | uM | LJP6 | 2 | B12 | 72 | hr | 1389 | 5724 | 5447 | 1.0507 | 1.0508 |
MCF7 | PD173074 | 0.04 | uM | LJP6 | 2 | I12 | 72 | hr | 1389 | 6431 | 5447 | 1.1804 | 1.1756 |
MCF7 | WH-4-025 | 0.04 | uM | LJP5 | 1 | O12 | 72 | hr | 1389 | 5266 | 5772 | 0.9123 | 0.9126 |
MCF7 | Mitoxantrone | 0.04 | uM | LJP6 | 3 | C24 | 72 | hr | 1389 | 1524 | 5740 | 0.2655 | 0.0463 |
MCF7 | Mitoxantrone | 0.04 | uM | LJP6 | 2 | C24 | 72 | hr | 1389 | 1585 | 5447 | 0.2909 | 0.0692 |